medicalps.eu
A step closer to the industrialization of LXRepair DNA Repair assays to predict the patients’ response to anticancer therapies - Medicalps
LXRepair, which develops unique functional tests to characterize DNA repair mechanisms in real time, is a winner of the French Major Investment Plan competition, managed by Bpifrance, for its ZYMONCO project. DNA Repair mechanisms determine the response of patients to different cancer treatments (radiotherapy, chemotherapy, PARP inhibitors, immunotherapy). The goal of the ZYMONCO program is …